V020-4751 Screening compound: 2-{4-[2-(4-CHLOROPHENOXY)ACETYL]PIPERAZIN-1-YL}-N-(CYCLOHEXYLMETHYL)-2-CYCLOPENTYLACETAMIDE

V020-4751 Screening compound: 2-{4-[2-(4-CHLOROPHENOXY)ACETYL]PIPERAZIN-1-YL}-N-(CYCLOHEXYLMETHYL)-2-CYCLOPENTYLACETAMIDE
V020-4751 Screening compound: 2-{4-[2-(4-CHLOROPHENOXY)ACETYL]PIPERAZIN-1-YL}-N-(CYCLOHEXYLMETHYL)-2-CYCLOPENTYLACETAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound V020-4751
2-{4-[2-(4-CHLOROPHENOXY)ACETYL]PIPERAZIN-1-YL}-N-(CYCLOHEXYLMETHYL)-2-CYCLOPENTYLACETAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V020-4751

Molecular Formula

C26H38ClN3O3 (C26 H38 ClN3 O3)

Compound Name

2-{4-[2-(4-CHLOROPHENOXY)ACETYL]PIPERAZIN-1-YL}-N-(CYCLOHEXYLMETHYL)-2-CYCLOPENTYLACETAMIDE

IUPAC name

n/a

SMILES

O=C(COc(cc1)ccc1Cl)N(CC1)CCN1C(C1CCCC1)C(NCC1CCCCC1)=O

InChI

InChI=1S/C26H38ClN3O3/c27-22-10-12-23(13-11-22)33-19-24(31)29-14-16-30(17-15-29)25(21-8-4-5-9-21)26(32)28-18-20-6-2-1-3-7-20/h10-13,20-21,25H,1-9,14-19H2,(H,28,32)/t25-/m0/s1

InChI Key

KVFMIOCINKFFSV-VWLOTQADSA-N

MDL Number (MFCD)

MFCD19880045

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

476.06

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.224

Distribution Coefficient, logD

4.218

Water Solubility, LogSw

-4.48

Polar Surface Area

51.855

Acid Dissociation Constant (pKa)

14.01

Base Dissociation Constant (pKb)

5.52

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

69.20

V020-4751 in Drug Discovery

Included in Screening Libraries

3D-Diversity Natural-Product-Like Library (18102 compounds)

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V020-4751 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V020-4751?
Check Price and Availability of V020-4751, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V020-4751 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V020-4751
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V020-4751
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V020-4751 available by request